Landmarks in insulin research

Frontiers in Endocrinology

Volumn 2, Issue NOV, 2011, Pages

  Ward, Colin W ^a   Lawrence, Michael C ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Insulin; Insulin receptor; Tyrosine kinase receptor

Indexed keywords

EID: 84862589994     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00076     Document Type: Review

References (92)

1. Abel, J. J. (1926). Crystalline insulin. Proc. Natl. Acad. Sci. U.S.A. 12, 132-136.
2. Adams, M. J., Blundell, T. L., Dodson, E. J., Dodson, G. G., Vijayan, M., Baker, E. N., Harding, M. M., Hodgkin, D. C., Rimmer, B., and Sheat, S.(1969). Structure of rhombohedral 2 zinc insulin crystals. Nature 224, 491-495.
3. Adams, T. E., Epa, V. C., Garrett, T. P., and Ward, C. W. (2000). Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57, 1050-1093.
4. Alvino, C. L., McNeil, K. A., Ong, S. C., Delaine, C., Booker, G. W., Wallace, J. C., Whittaker, J., and Forbes, B. E. (2009). A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. J. Biol Chem. 284, 7656-7664.
5. Banting, F. G., Best, C. H., Col-lip, J. B., Campbell, W. R., Fletcher, A. A., MacLeod, J. J. R., and Noble, E. C. (1922). The effect produced on diabetes by extracts of pancreas. Trans. Assoc. Am. Physicians 37, 337-347.
6. Bass, J., Chiu, G., Argon, Y., and Steiner, D. F. (1998). Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J. Cell Biol. 141, 637-646.
7. Beijing Insulin Structure Group. (1972). Studies on crystal structure of insulin at 2.5Å. Sci. Sin. 1, 3-30.
8. Bentley, G., Dodson, E., Dodson, G., Hodgkin,D.,andMercola,D. (1976). Structure of insulin in 4-zinc insulin. Nature 261,166-168.
9. Bliss, M. (1982). The Discovery of Insulin. Toronto: McLellan and Stewart.
10. Borg, J. P., and Margolis, B. (1998). Function of PTB domains. Curr. Top. Microbiol. Immunol. 228, 23-38.
11. Brange, J., Owens, D. R., Kang, S., and Volund, A. (1990). Monomeric insulins and their experimental and clinical implications. Diabetes Care 13,923-954.
12. Chan, S. J., Nakagawa, S., and Steiner, D. F. (2007). Complementation analysis demonstrates that insulin crosslinks both a subunits in a truncated insulin receptor dimer. J. Biol. Chem. 282,13754-13758.
13. Chance, R. E., Ellis, R. M., and Bromer, W. W. (1968). Porcine proinsulin: characterization and amino acid sequence. Science 161,165-167.
14. Chiacchia, K. B. (1991). Quantitation of the class I disulfides of the insulin receptor. Biochem. Biophys. Res. Commun. 176,1178-1182.
15. Cosgrove, L., Lovrecz, G. O., Verkuylen, A., Cavaleri, L., Black, L. A., Bent-ley, J. D., Howlett, G. J., Gray, P. P., Ward, C. W., and McKern, N. M. (1995). Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. Protein Expr. Purif. 6, 789-798.
16. Craddock, B. P., Cotter, C., and Miller, W. T. (2007). Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region. FEBS Lett. 581,3235-3240.
17. Crowfoot, D. (1935). X-ray single crystal photographs of insulin. Nature 135,591-592.
18. Cuatrecasas, P., Desbuquois, B., and Krug, F. (1971). Insulin-receptor interactions in liver cell membranes. Biochem. Biophys. Res. Commun. 44, 333-339.
19. De Meyts, P. (1994). The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37(Suppl. 2), S135-S148.
20. De Meyts, P. (2004). Insulin and its receptor: structure, function and evolution. Bioessays 26,1351-1362.
21. Denley, A., Bonython, E. R., Booker, G. W., Cosgrove, L. J., Forbes, B. E., Ward, C. W., and Wallace, J. C. (2004). Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus iso-form of the IR. Mol. Endocrinol. 18, 2502-2512.
22. Derewenda, U., Derewenda, Z., Dodson, E. J., Dodson, G. G., Bing, X., and Markussen, J. (1991). X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. J. Mol. Biol. 220,425-433.
23. Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J. H., Masiarz, F., Kan, Y. W., Goldfine, I. D., Roth, R. A., and Rutter, W. J. (1985). The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747-758.
24. Finn, F. M., Ridge, K. D., and Hofmann, K. (1990). Labile disulfide bonds in human placental insulin receptor. Proc. Natl. Acad. Sci. U.S.A. 87, 419-423.
25. Frasca, F., Pandini, G., Scalia, P., Sci-acca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., and Vigneri, R. (1999). Insulin receptor isof orm A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 19, 3278-3288.
26. Freychet, P., Roth, J., and Neville, D. M. Jr. (1971). Insulin receptors in the liver: specific binding of [125I]insulin to the plasma membrane and its relation to insulin bioactivity. Proc. Natl. Acad. Sci. U.S.A. 68, 1833-1837.
27. Gammeltoft, S., and Gliemann, J. (1973). Binding and degradation of 125I-labelled insulin by isolated rat fat cells. Biochim. Biophys. Acta 320, 16-32.
28. Garrett, T. P., McKern, N. M., Lou, M., Frenkel, M. J., Bentley, J. D., Lovrecz, G. O., Elleman, T. C., Cosgrove, L. J., and Ward, C.W. (1998). Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394, 395-399.
29. Gauguin, L., Delaine, C., Alvino, C. L., McNeil, K. A., Wallace, J. C., Forbes, B. E., and De Meyts, P. (2008). Ala-nine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 283, 20821-20829.
30. Glendorf, T., Sorensen, A. R., Nishimura, E., Pettersson, I., and Kjeldsen, T. (2008). Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding. Biochemistry 47, 4743-4751.
31. House, P. D., and Weidemann, M. J. (1970). Characterization of an [125 I]-insulin binding plasma membrane fraction from rat liver. Biochem. Biophys. Res. Commun. 41, 541-548.
32. Hua, Q. X., Shoelson, S. E., Kochoyan, M., and Weiss, M. A. (1991). Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354, 238-241.
33. Hubbard, S. R. (1997). Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBOJ. 16,5572-5581.
34. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
35. Jensen, A.-M. (2000). Analysis of Structure-Activity Relationships of the Insulin Molecule by Alanine ScanningMutagenesis. Master's Thesis, The University of Copenhagen, Copenhagen.
36. Jiracek, J., Zakova, L., Antolikova, E., Watson, C. J., Turkenburg, J. P., Dodson, G. G., and Brzozowski, A. M. (2010). Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc. Natl. Acad. Sci. U.S.A. 107, 1966-1970.
37. Johnston, A. M., Pirola, L., and Van Obberghen, E. (2003). Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 546, 32-36.
38. Kasuga, M., Zick, Y., Blith, D. L., Karls-son, F. A., Haring, H. U., and Kahn, C. R. (1982a). Insulin stimulation of phosphorylation of the beta sub-unit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. J. Biol. Chem. 257, 9891-9894.
39. Kasuga, M., Zick, Y., Blithe, D. L., Cret-taz, M., and Kahn, C. R. (1982b). Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298, 667-669.
40. King, K. M. (2003). A history of insulin: from discovery to modern alternatives. Br. I Nurs. 12, 1137-1141.
41. Knighton, D. R., Zheng, J. H., Ten Eyck, L. F., Xuong, N. H., Taylor, S. S., and Sowadski, J. M. (1991). Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adeno-sine monophosphate-dependent protein kinase. Science 253, 414-420.
42. Kristensen, C., Andersen, A. S., Øster-gaard, S., Hansen, P. H., and Brandt, J. (2002). Functional reconstitution of insulin receptor binding site from non-binding receptor fragments. J. Biol. Chem. 277, 18340-18345.
43. Kristensen, C., Wiberg, F. C., Schäf-fer, L., and Andersen, A. S. (1998). Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. Minimizing ligand binding domain of the insulin receptor. J. Biol. Chem. 273, 17780-17786.
44. Kurose, T., Pashmforoush, M., Yoshi-masa, Y., Carroll, R., Schwartz, G. P., Burke, G. T., Katsoyannis, P. G., and Steiner, D. F. (1994). Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the α-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. J. Biol. Chem. 269, 29190-29197.
45. Lawrence, M. C., McKern, N. M., and Ward, C. W (2007). Insulin receptor structure and its implications for the IGF-1 receptor. Curr. Opin. Struct. Biol. 17, 699-705.
46. Levine, R., Goldstein, M., Klein, S., and Huddlestun, B. (1949). The action of insulin on the distribution of galactose in eviscerated nephrec-tomized dogs. J. Biol. Chem. 179, 985.
47. Li, S., Covino, N. D., Stein, E. G., Till, J. H., and Hubbard, S. R. (2003). Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 278,26007-26014.
48. Lou, M., Garrett, T. P., McKern, N. M., Hoyne, P. A., Epa, V. C., Bentley, J. D., Lovrecz, G. O., Cosgrove, L. J., Frenkel, M. J., and Ward, C. W (2006). The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 103, 12429-12434.
49. Ludvigsen, S., Olsen, H. B., and Kaarsholm, N. C. (1998). A structural switch in a mutant insulin exposes key residues for receptor binding. J. Mol. Biol. 279, 1-7.
50. Machida, K., Thompson, C. M., Dierck, K., Jablonowski, K., Karkkainen, S., Liu, B., Zhang, H., Nash, P. D., Newman, D. K., Nollau, P., Paw-son, T., Renkema, G. H., Saksela, K., Schiller, M. R., Shin, D. G., and Mayer, B. J. (2007). High-throughput phosphotyrosine profiling using SH2 domains. Mol. Cell 26, 899-915.
51. Massague, J., Pilch, P. F., and Czech, M. P. (1980). Electrophoretic resolution of three major insulin receptor structures with unique subunit sto-ichiometries. Proc. Natl. Acad. Sci. U.S.A. 77, 7137-7141.
52. McKern, N. M., Lawrence, M. C., Streltsov, V. A., Lou, M. Z., Adams, T. E., Lovrecz, G. O., Elleman, T. C., Richards, K. M., Bentley, J. D., Pilling, P. A., Hoyne, P. A., Cartledge, K. A., Pham, T. M., Lewis, J. L., Sankovich, S. E., Stoichevska, V., Da Silva, E., Robinson, C. P., Frenkel, M. J., Sparrow, L. G., Fernley, R. T., Epa, V. C., and Ward, C. W. (2006). Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 443, 218-221.
53. Menting, J. G., Ward, C. W., Margetts, M. B., and Lawrence, M. C. (2009). A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor α-chain C-terminal peptide and the site 1 insulin mimetic peptides. Biochemistry 48,5492-5500.
54. Mynarcik, D. C., Williams, P. F., Schäf-fer, L., Yu, G. Q., and Whittaker, J. (1997). Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding. J. Biol. Chem. 272, 18650-18655.
55. Mynarcik, D. C., Yu, G. Q., and Whittaker, J. (1996). Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor α subunit. J. Biol. Chem. 271, 2439-2442.
56. Nakagawa, S. H., Zhao, M., Hua, Q. X., Hu, S. Q., Wan, Z. L., Jia, W., and Weiss, M. A. (2005). Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain. Biochemistry 44, 4984-4999.
57. Novo Nordisk. (2009). History ofNovo Nordisk. Available: http:// www. novonordisk.com.au/documents/ article_ page/document/ History.asp
58. Pawson, T., Gish, G. D., and Nash, P. (2001). SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11,504-511.
59. Rosenfeld, L. (2002). Insulin: discovery and controversy. Clin. Chem. 48, 2270-2288.
60. Sanger, E (1949). Fractionation of oxidized insulin. Biochem. J. 44, 126-128.
61. Sanger, F., and Thompson, E. O. (1953a). The amino-acid sequence in the glycyl chain of insulin. I. The identification of lower peptides from partial hydrolysates. Biochem. J. 53, 353-366.
62. Sanger, F., and Thompson, E. O. (1953b). The amino-acid sequence in the glycyl chain of insulin. II. The investigation of peptides from enzymic hydrolysates. Biochem. J. 53, 366-374.
63. Sanger, F., and Tuppy, H. (1951a). The amino-acid sequence in the pheny-lalanyl chain of insulin. 1. The identification of lower peptides from partial hydrolysates. Biochem. J. 49, 463-481.
64. Sanger, F., and Tuppy, H. (1951b). The amino-acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates. Biochem. J. 49, 481-490.
65. Schäffer, L. (1994). A model for insulin binding to the insulin receptor. Eur. I Biochem.221, 1127-1132.
66. Shabanpoor, F., Separovic, F., and Wade, J. D. (2009). The human insulin superfamily of polypeptide hormones. Vitam. Horm. 80,1-31.
67. Siddle, K. (2011). Signalling by insulin and IGF receptors: supporting acts and new players. J. Mol. Endocrinol. 47, R1-R10.
68. Sjögren,B.,andSvedberg,T. (1931).The molecular weight of insulin. J. Am. Chem. Soc. 53,2657-2661.
69. Smeekens, S. P., Avruch, A. S., LaMen-dola, J., Chan, S. J., and Steiner, D. E (1991). Identification of a cDNA encoding a second putative prohor-mone convertase related to PC2 in AtT20 cells and islets of Langer-hans. Proc. Natl. Acad. Sci. U.S.A. 88, 340-344.
70. Smeekens,S. P.,and Steiner, D.F. (1990). Identification of a human insuli-noma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. J. Biol. Chem. 265, 2997-3000.
71. Smith, B. J., Huang, K., Kong, G., Chan, S. J., Nakagawa, S., Menting, J. G., Hu, S.-Q., Whittaker, J., Steiner, D. F., Katsoyannis, P. G., Ward, C. W., Weiss, M. A., and Lawrence, M. C. (2010). Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists. Proc. Natl. Acad. Sci. U.S.A. 107, 6771-6776.
72. Soos, M. A., Siddle, K., Baron, M. D., Heward, J. M., Luzio, J. P., Bellatin, J., and Lennox, E. S. (1986). Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem. J. 235,199-208.
73. Sparrow, L. G., Gorman, J. J., Strike, P. M., Robinson, C. P., McKern, N. M., Epa, V. C., and Ward, C. W. (2007a). The location and characterisation of the O-linked glycans of the human insulin receptor. Proteins Struct. Funct. Bioinform. 66, 261-265.
74. Sparrow, L. G., Lawrence, M. C., Gorman, J. J., Strike, P. M., Robinson, C. P., McKern, N. M., and Ward, C. W. (2007b). N-linked glycans of the human insulin receptor and their distribution over the crystal structure. Proteins Struct. Funct. Bioinform. 71,426-439.
75. Sparrow, L. G., McKern, N. M., Gorman, J. J., Strike, P. M., Robinson, C. P., Bentley, J. D., and Ward, C. W. (1997). The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain. J. Biol. Chem. 272, 29460-29467.
76. Steiner, D. E (2011). Adventures with Insulin in the Islets of Langerhans. J. Biol. Chem. 286, 17399-17241.
77. Steiner, D. F., Cunningham, D., Spigel-man, L.,andAten, B. (1967). Insulin biosynthesis: evidence for a precursor. Science 157,697-700.
78. Steiner, D. F., and Oyer, P. E. (1967). The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc. Natl. Acad. Sci. U.S.A. 57, 473-480.
79. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. E (1991). Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77.
80. Surinya, K. H., Molina, L., Soos, M. A., Brandt, J., Kristensen, C., and Siddle, K. (2002). Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. J. Biol. Chem. 277,16718-16725.
81. Ullrich, A., Bell, J. R., Chen, E. Y., Her-rera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M., Mason, A., See-burg, P. H., Grunfeld, C., Rosen, O. M., and Ramachandran, J. (1985). Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313,756-761.
82. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C.,Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jaobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. (1986). Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBOJ. 5,2503-2512.
83. Ward, C., Lawrence, M., Streltsov, V., Garrett, T., McKern, N., Lou, M. Z., Lovrecz, G., and Adams, T. (2008). Structural insights into ligand-induced activation of the insulin receptor. Acta Physiol. (Oxf.) 192, 3-9.
84. Ward, C. W., Gough, K. H., Rashke, M., Wan, S. S., Tribbick, G., and Wang, J. (1996). Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J. Biol. Chem. 271, 5603-5609.
85. Ward, C. W., Hoyne, P. A., and Flegg, R. H. (1995). Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor. Proteins 22,141-153.
86. Ward, C. W., and Lawrence, M. C. (2009). Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 31, 422-434.
87. Ward, C. W., Lawrence, M. C., Streltsov, V. A., Adams, T. E., and McKern, N. M. (2007). The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. Trends Biochem. Sci. 32, 129-137.
88. Weiss, M. A. (2009). The structure and function of insulin decoding the TR transition. Vitam. Horm. 80, 33-49.
89. White, M. F., Maron, R., and Kahn, C. R. (1985). Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318, 183-186.
90. Wolf, G., Trub, T., Ottinger, E., Groninga, L., Lynch, A., White, M. F., Miyazaki, M., Lee, J., and Shoel-son, S. E. (1995). PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270,27407-27410.
91. Xu, B., Hu, S. Q., Chu, Y C, Huang, K., Nakagawa, S. H., Whittaker, J., Katsoyannis, P. G., and Weiss, M. A. (2004). Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Biochemistry 43, 8356-8372.
92. Xu, B., Huang, K., Chu, Y. C., Hu, S. Q., Nakagawa, S., Wang, S., Wang, R. Y., Whittaker, J., Katsoyannis, P. G., and Weiss, M. A. (2009). Decoding the cryptic active conformation of a protein by synthetic photo-scanning. Insulin inserts a detachable arm between receptor domains. J. Biol Chem. 284,14597-14608